Now: A more efficient way to diverse, actionable antibody candidates

Preview text: Now: A more efficient way to diverse, actionable antibody candidates 96 Learn how you can…

Wednesday, Apr 29, 2026 at 11:33 AM EasternHubSpot

Antibody SolutionsNow: A more efficient way to diverse, actionable antibody candidates

Image not available

No image available for this email.

Subject: Now: A more efficient way to diverse, actionable antibody candidates
Preview text: Now: A more efficient way to diverse, actionable antibody candidates 96 Learn how you can…
From: marketing@antibody.com
Brand: Antibody Solutions
ESP: HubSpot
Sent: Wed Apr 29, 2026, 11:33 AM ET
Size: 94 KB
Images: 8
Links: 17, 3 of them buttons
Subject length: 69 characters

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Debra Valsamis <[email protected]>
Reply-To: [email protected]
Subject: Now: A more efficient way to diverse, actionable antibody candidates
Date: Wed, 29 Apr 2026 11:33:54 -0400
Message-ID domain: bf10.na2.hubspotemail.net
Return-Path domain: bf10.na2.hubspotemail.net
DKIM signature: d=bf10.na2.hubspotemail.net s=hs2; d=antibody.com s=hs2
Authentication: dkim=pass (bf10.na2.hubspotemail.net), dkim=pass (antibody.com), spf=pass (bf10.na2.hubspotemail.net), dmarc=pass (antibody.com)
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

from byc96m2.bf10.na2.hubspotemail.net [216.139.64.140] by our receiving server with ESMTPS

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

Sent just before and after

	Jul 23, 2026 12:08 PM	Part 2: Exploring Antibody Discovery in 2026
	Jun 24, 2026 3:56 PM	Optimize Your ADA Assay Development
	Jun 1, 2026 10:16 AM	A handy, three-minute recap of PEGS 2026
	May 7, 2026 3:57 PM	Find your way to ” yes” in Ab discovery at PEGS 2026
	Apr 29, 2026 11:33 AM	Now: A more efficient way to diverse, actionable antibody candidates (this email)
	Mar 19, 2026 2:26 PM	Part 1: The State of Antibody Discovery in 2026
	Mar 16, 2026 2:06 PM	Stuck on a low-immunogenicity target?